Quality Services • CAP & CLIA Accredited
seniors wellness care logo
seniors wellness care name
Genetic Testing & Molecular Diagnostics
Preserve Vision • Macular & Glaucoma GeneticsPANEL-OPH-20

Inherited Ophthalmic & Vision Health

Many degenerative eye diseases progress silently before irreversible optic nerve or retinal damage occurs. This panel investigates genetic variants associated with age-related macular degeneration (AMD), juvenile and open-angle glaucoma, and inherited retinal dystrophies—enabling ophthalmologists to implement early vision-saving interventions and targeted antioxidant therapies.

Ophthalmic Genes20 Targets
Turnaround Time7–10 Days
CollectionCheek Swab
Lab CertifiedCLIA & CAP

Check If You Qualify

Takes under 2 minutes • Quick Pre-Qualification

Check Eligibility →
HIPAA 256-Bit Encrypted

Who Should Consider This Screening?

Healthcare providers recommend this diagnostic panel for individuals with the following personal or family health indicators:

Early onset of macular degeneration symptoms before age 60.
Immediate family member diagnosed with glaucoma at a young age (<50 years).
Unexplained progressive loss of night vision or peripheral visual fields.
Family history of inherited retinal dystrophy or Stargardt disease.

Biomarkers & Genes Evaluated in this Panel

Processed using high-complexity Next-Generation Sequencing (NGS) in CLIA-certified and CAP-accredited partner laboratories.

Gene Symbol / NameClinical SignificanceActionable Impact
ABCA4 & BEST1Retinal ATP-Binding Cassette TransportersPrimary loci for Stargardt disease, vitelliform macular dystrophy, and inherited maculopathies.Directs strict blue-light/UV protection, AREDS2 nutritional adjustments, and micro-perimetry tracking.
MYOC & OPTNMyocilin & Optineurin Trabecular RegulatorsAssociated with early-onset primary open-angle glaucoma and normal-tension glaucoma.Guides proactive intraocular pressure (IOP) reduction protocols before visual field constriction occurs.
RPGR & RHORetinitis Pigmentosa GTPase & Rhodopsin PhotoreceptorsCritical for rod and cone photoreceptor maintenance and dark adaptation.Qualifies eligible patients for emerging gene therapy protocols and specialized low-vision rehabilitation.

Sample Report & Diagnostic Action Plan

Every patient receives an easy-to-understand diagnostic summary and a detailed clinical report tailored for their primary care doctor.

Sample Result ClassificationModerate Risk Factor
Identified Finding:

High-risk susceptibility alleles detected in complement factor H (CFH) and ARMS2 macular risk loci.

Clinician Recommendation:

Recommend semi-annual dilated retinal exams, Amsler grid self-monitoring, and initiating AREDS 2 formula antioxidant supplementation.

Clinical Care & Laboratory Standards

How our licensed physician network and accredited laboratories deliver personalized diagnostic clarity to your doorstep:

100% Physician-Ordered & CLIA Lab Certified

Physician-ordered ophthalmic genomic testing analyzes 20 retinal and trabecular biomarkers to detect early genetic risks for macular degeneration, glaucoma, and inherited vision loss.

Our network of state-licensed physicians reviews your clinical indications to confirm medical necessity and coordinate care before any kit is mailed.
Physician-Ordered Clinical Screening

Ready to Check Your Eligibility for Inherited Ophthalmic & Vision Health?

Takes under 2 minutes • Painless at-home cheek swab • 100% Physician Reviewed

Start 2-Minute Pre-Qualification →